Multivariate data analysis of process parameters affecting the growth and productivity of stable Chinese hamster ovary cell pools expressing SARS-CoV-2 spike protein as vaccine antigen in early process development.

CHO stable pool Cumate induction MVDA SARS‐CoV‐2 trimeric spike protein fed‐batch bioreactor production random forest

Journal

Biotechnology progress
ISSN: 1520-6033
Titre abrégé: Biotechnol Prog
Pays: United States
ID NLM: 8506292

Informations de publication

Date de publication:
25 Apr 2024
Historique:
revised: 25 03 2024
received: 05 01 2024
accepted: 28 03 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 25 4 2024
Statut: aheadofprint

Résumé

The recent COVID-19 pandemic revealed an urgent need to develop robust cell culture platforms which can react rapidly to respond to this kind of global health issue. Chinese hamster ovary (CHO) stable pools can be a vital alternative to quickly provide gram amounts of recombinant proteins required for early-phase clinical assays. In this study, we analyze early process development data of recombinant trimeric spike protein Cumate-inducible manufacturing platform utilizing CHO stable pool as a preferred production host across three different stirred-tank bioreactor scales (0.75, 1, and 10 L). The impact of cell passage number as an indicator of cell age, methionine sulfoximine (MSX) concentration as a selection pressure, and cell seeding density was investigated using stable pools expressing three variants of concern. Multivariate data analysis with principal component analysis and batch-wise unfolding technique was applied to evaluate the effect of critical process parameters on production variability and a random forest (RF) model was developed to forecast protein production. In order to further improve process understanding, the RF model was analyzed with Shapley value dependency plots so as to determine what ranges of variables were most associated with increased protein production. Increasing longevity, controlling lactate build-up, and altering pH deadband are considered promising approaches to improve overall culture outcomes. The results also demonstrated that these pools are in general stable expressing similar level of spike proteins up to cell passage 11 (~31 cell generations). This enables to expand enough cells required to seed large volume of 200-2000 L bioreactor.

Identifiants

pubmed: 38660973
doi: 10.1002/btpr.3467
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3467

Subventions

Organisme : Natural Sciences and Engineering Research Council of Canada, NSERC-CREATE PrEEmiuM
ID : RGPIN/4048-2021
Organisme : National Research Council Canada
ID : PR-023-1

Informations de copyright

© 2024 National Research Council Canada. Biotechnology Progress published by Wiley‐VCH GmbH on behalf of American Institute of Chemical Engineers. Reproduced with the permission of the Minister of Innovation, Science, and Economic Development.

Références

Hacker DL, Balasubramanian S. Recombinant protein production from stable mammalian cell lines and pools. Curr Opin Struct Biol. 2016;38:129‐136. doi:10.1016/j.sbi.2016.06.005
Stuible M, Gervais C, Lord‐Dufour S, et al. Rapid, high‐yield production of full‐length SARS‐CoV‐2 spike ectodomain by transient gene expression in CHO cells. J Biotechnol. 2021;326:21‐27. doi:10.1016/j.jbiotec.2020.12.005
Joubert S, Stuible M, Lord‐Dufour S, et al. A CHO stable pool production platform for rapid clinical development of trimeric SARS‐CoV‐2 spike subunit vaccine antigens. Biotechnol Bioeng. 2023;120(7):1746‐1761.
Stuible M, van Lier F, Croughan MS, Durocher Y. Beyond preclinical research: production of CHO‐derived biotherapeutics for toxicology and early‐phase trials by transient gene expression or stable pools. Curr Opin Chem Eng. 2018;22:145‐151. doi:10.1016/j.coche.2018.09.010
Ye J, Alvin K, Latif H, et al. Rapid protein production using CHO stable transfection pools. Biotechnol Prog. 2010;26(5):1431‐1437. doi:10.1002/btpr.469
Reyes SJ, Durocher Y, Pham PL, Henry O. Modern sensor tools and techniques for monitoring, controlling, and improving cell culture processes. Processes. 2022;10(2):189‐225. doi:10.3390/pr10020189
Molina RS, Molina‐Rodríguez MA, Rincón FM, Maldonado JD. Cardiac operative risk in Latin America: a comparison of machine learning models vs EuroSCORE‐II. Ann Thorac Surg. 2022;113(1):92‐99.
Alavijeh MK, Baker I, Lee YY, Gras SL. Digitally enabled approaches for the scale up of mammalian cell bioreactors. Digital Chem Eng. 2022;4:100040.
Irfan K. Carbon Dioxide Control in Bioreactors and the Application of Principal Component Analysis to Cell Culture Process Data. Dissertation. Newcastle University. 2017.
Tescione L, Lambropoulos J, Paranandi MR, Makagiansar H, Ryll T. Application of bioreactor design principles and multivariate analysis for development of cell culture scale down models. Biotechnol Bioeng. 2015;112(1):84‐97.
Rathore AS, Mittal S, Pathak M, Mahalingam V. Chemometrics application in biotech processes: assessing comparability across processes and scales. J Chem Technol Biotechnol. 2014;89(9):1311‐1316. doi:10.1002/jctb.4428
Goldrick S, Sandner V, Cheeks M, et al. Multivariate data analysis methodology to solve data challenges related to scale‐up model validation and missing data on a micro‐bioreactor system. Biotechnol J. 2020;15(3):1800684. doi:10.1002/biot.201800684
Facco P, Zomer S, Rowland‐Jones RC, et al. Using data analytics to accelerate biopharmaceutical process scale‐up. Biochem Eng J. 2020;164:107791. doi:10.1016/j.bej.2020.107791
Powers DN, Trunfio N, Velugula‐Yellela SR, Angart P, Faustino A, Agarabi C. Multivariate data analysis of growth medium trends affecting antibody glycosylation. Biotechnol Prog. 2020;36(1):e2903.
Nomikos P, MacGregor JF. Monitoring batch processes using multiway principal component analysis. AIChE J. 1994;40(8):1361‐1375. doi:10.1002/aic.690400809
Wold S, Kettaneh N, Fridén H, Holmberg A. Modelling and diagnostics of batch processes and analogous kinetic experiments. Chemometric Intell Lab Syst. 1998;44(1–2):331‐340.
Glassey J. Multivariate data analysis for advancing the interpretation of bioprocess measurement and monitoring data. Adv Biochem Eng Biotechnol. 2013;132:167‐191. doi:10.1007/10_2012_171
Mercier SM, Diepenbroek B, Dalm MC, Wijffels RH, Streefland M. Multivariate data analysis as a PAT tool for early bioprocess development data. J Biotechnol. 2013;167(3):262‐270.
Suarez‐Zuluaga DA, Borchert D, Driessen NN, Bakker WAM, Thomassen YE. Accelerating bioprocess development by analysis of all available data: a USP case study. Vaccine. 2019;37(47):7081‐7089. doi:10.1016/j.vaccine.2019.07.026
Roychoudhury P, O'Kennedy R, Faulkner J, McNeil B, Harvey LM. Implementing multivariate data analysis to monitor mammalian cell culture processes. Eur Pharmac Rev. 2013;18(3):15‐20.
Kirdar AO, Conner JS, Baclaski J, Rathore AS. Application of multivariate analysis toward biotech processes: case study of a cell‐culture unit operation. Biotechnol Prog. 2007;23(1):61‐67.
Tsang VL, Wang AX, Yusuf‐Makagiansar H, Ryll T. Development of a scale down cell culture model using multivariate analysis as a qualification tool. Biotechnol Prog. 2014;30(1):152‐160.
Salim T, Chauhan G, Templeton N, Ling WLW. Using MVDA with stoichiometric balances to optimize amino acid concentrations in chemically defined CHO cell culture medium for improved culture performance. Biotechnol Bioeng. 2022;119(2):452‐469.
Ding X, Liu J, Yang F, Cao J. Random radial basis function kernel‐based support vector machine. J Franklin Inst. 2021;358(18):10121‐10140. doi:10.1016/j.jfranklin.2021.10.005
Le H, Kabbur S, Pollastrini L, et al. Multivariate analysis of cell culture bioprocess data—lactate consumption as process indicator. J Biotechnol. 2012;162(2–3):210‐223.
Hassan SS, Farhan M, Mangayil R, Huttunen H, Aho T. Bioprocess data mining using regularized regression and random forests. BMC Syst Biol. 2013;7(1):1‐7.
Rafferty C, Johnson K, O'Mahony J, Burgoyne B, Rea R, Balss KM. Analysis of chemometric models applied to Raman spectroscopy for monitoring key metabolites of cell culture. Biotechnol Prog. 2020;36(4):e2977.
Park S‐Y, Kim S‐J, Park C‐H, Kim J, Lee D‐Y. Data‐driven prediction models for forecasting multistep ahead profiles of mammalian cell culture toward bioprocess digital twins. Biotechnol Bioeng. 2023;120:2494‐2508. doi:10.1002/bit.28405
Poulain A, Perret S, Malenfant F, Mullick A, Massie B, Durocher Y. Rapid protein production from stable CHO cell pools using plasmid vector and the cumate gene‐switch. J Biotechnol. 2017;255:16‐27. doi:10.1016/j.jbiotec.2017.06.009
Kucheryavskiy S. Mdatools – R package for chemometrics. Chemom Intel Lab Syst. 2020;198:103937. doi:10.1016/j.chemolab.2020.103937
Kuhn M, Wing J, Weston S, et al. Package ‘caret’ 2020;223:7.
Signal: Signal processing. 2014 http://r-forge.r-project.org/projects/signal/
Davison AC, Hinkley DV. Bootstrap Methods and their Application. Cambridge university press; 1997.
Canty A. Ripley BJCsRfhcr‐Powpb. Boot: Bootstrap R (S‐Plus) Functions. R package version 1.3‐18. 2016.
Greenwell B, Greenwell MB. Package ‘fastshap’. 2020.
Lin J, Takagi M, Qu Y, Yoshida T. Possible strategy for on‐line monitoring and control of hybridoma cell culture. Biochem Eng J. 2002;11(2–3):205‐209.
Hippach M, Schwartz I, Pei J, Huynh J, Kawai Y, Zhu M. Fluctuations in dissolved oxygen concentration during a CHO cell culture process affects monoclonal antibody productivity and the sulfhydryl‐drug conjugation process. Biotechnol Prog. 2018;34(6):1427‐1437.
Tian J, He Q, Oliveira C, et al. Increased MSX level improves biological productivity and production stability in multiple recombinant GS CHO cell lines. Eng Life Sci. 2020;20(3–4):112‐125.
Kuhn M. Futility analysis in the cross‐validation of machine learning models. arXiv preprint arXiv:14056974. 2014.
Aman F, Rauf A, Ali R, Hussain J, Ahmed I. Balancing complex signals for robust predictive modeling. Sensors. 2021;21(24):8465‐8483. doi:10.3390/s21248465
Nohara Y, Matsumoto K, Soejima H, Nakashima N. Explanation of machine learning models using shapley additive explanation and application for real data in hospital. Comput Methods Programs Biomed. 2022;214:106584. doi:10.1016/j.cmpb.2021.106584
Yang R. Who dies from COVID‐19? Post‐hoc explanations of mortality prediction models using coalitional game theory, surrogate trees, and partial dependence plots. MedRxiv. 2020;2020(6):07.20124933. doi:10.1101/2020.06.07.20124933
Scapin D, Cisotto G, Gindullina E, Badia L. Shapley value as an aid to biomedical machine learning: a heart disease dataset analysis. IEEE. 2022;933‐939.
Rozemberczki B, Watson L, Bayer P, et al. The shapley value in machine learning. arXiv preprint arXiv:220205594. 2022.
Lundberg S, Lee S‐I. A unified approach to interpreting model predictions. Adv Neur Inform Process Syst. 2017;30:4768‐4777.
Xiao S, Ahmed W, Mohsin A, Guo M. Continuous feeding reduces the generation of metabolic byproducts and increases antibodies expression in Chinese hamster ovary‐K1 cells. Life. 2021;11(9):945.
Grilo AL, Mantalaris A. Apoptosis: a mammalian cell bioprocessing perspective. Biotechnol Adv. 2019;37(3):459‐475.
Hoshan L, Jiang R, Moroney J, et al. Effective bioreactor pH control using only sparging gases. Biotechnol Prog. 2019;35(1):e2743. doi:10.1002/btpr.2743
Betts J, Warr S, Finka G, et al. Impact of aeration strategies on fed‐batch cell culture kinetics in a single‐use 24‐well miniature bioreactor. Biochem Eng J. 2014;82:105‐116.
Wagner BA, Venkataraman S, Buettner GR. The rate of oxygen utilization by cells. Free Radic Biol Med. 2011;51(3):700‐712.
Downey BJ, Graham LJ, Breit JF, Glutting NK. A novel approach for using dielectric spectroscopy to predict viable cell volume (VCV) in early process development. Biotechnol Prog. 2014;30(2):479‐487. doi:10.1002/btpr.1845
Opel CF, Li J, Amanullah A. Quantitative modeling of viable cell density, cell size, intracellular conductivity, and membrane capacitance in batch and fed‐batch CHO processes using dielectric spectroscopy. Biotechnol Prog. 2010;26(4):1187‐1199. doi:10.1002/btpr.425
Pan X, Dalm C, Wijffels RH, Martens DE. Metabolic characterization of a CHO cell size increase phase in fed‐batch cultures. Appl Microbiol Biotechnol. 2017;101(22):8101‐8113. doi:10.1007/s00253‐017‐8531‐y
Lloyd DR, Holmes P, Jackson LP, Emery AN, Al‐Rubeai M. Relationship between cell size, cell cycle and specific recombinant protein productivity. Cytotechnology. 2000;34(1–2):59‐70. doi:10.1023/a:1008103730027
Huang YM, Hu W, Rustandi E, Chang K, Yusuf‐Makagiansar H, Ryll T. Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog. 2010;26(5):1400‐1410.
Pappenreiter M, Sissolak B, Sommeregger W, Striedner G. Oxygen uptake rate soft‐sensing via dynamic kLa computation: cell volume and metabolic transition prediction in mammalian bioprocesses. Front Bioeng Biotechnol Adv. 2019;7:195.
Wallocha T, Popp O. Off‐gas‐based soft sensor for real‐time monitoring of biomass and metabolism in Chinese hamster ovary cell continuous processes in single‐use bioreactors. Processes. 2021;9(11):2073.
Kuystermans D, Al‐Rubeai M. Bioreactor systems for producing antibody from mammalian cells. Antibody Exp Produc. 2011; 7:25‐52.
Krampe B, Al‐Rubeai M. Cell death in mammalian cell culture: molecular mechanisms and cell line engineering strategies. Cytotechnology. 2010;62(3):175‐188. doi:10.1007/s10616‐010‐9274‐0

Auteurs

Sebastian-Juan Reyes (SJ)

Department of Chemical Engineering, Polytechnique Montreal, Montreal, Canada.
Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Lucas Lemire (L)

Department of Chemical Engineering, Polytechnique Montreal, Montreal, Canada.
Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Raul-Santiago Molina (RS)

Proelium S.A.S, Bogotá, Colombia.

Marjolaine Roy (M)

Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Helene L'Ecuyer-Coelho (H)

Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Yuliya Martynova (Y)

Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Brian Cass (B)

Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Robert Voyer (R)

Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Yves Durocher (Y)

Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Olivier Henry (O)

Department of Chemical Engineering, Polytechnique Montreal, Montreal, Canada.

Phuong Lan Pham (PL)

Human Health Therapeutics Research Centre, National Research Council Canada, Canada.

Classifications MeSH